BCL7B and glioblastoma: OS showed that BCL7B was significantly related to the prognosis of GBM (p = 0.014), glioma (GBMLGG, p < 0.001), KICH (p = 0.041), KIRC (p = 0.022), LGG (p = 0.001), OSCC (p = 0.035), sarcoma (SARC, p = 0.002), and uveal melanoma (UVM, p = 0.045) (Figure 1C, Figures 2A–H).